Home ProductsRecombinant Human Albumin

Cell Culture Grade Recombinant Human Albumin / 66.5 KDa Recombinant HSA

Certification
China Wuhan Healthgen Biotechnology Corp. certification
China Wuhan Healthgen Biotechnology Corp. certification
Customer Reviews
Awesome company, highly recommended for Healthgen Biotech updates.

—— David Castillo

Healthgen Biotech has always been committed to science and scientists. Hope you will do well in new field too.

—— Frank Schauer

I'm Online Chat Now

Cell Culture Grade Recombinant Human Albumin / 66.5 KDa Recombinant HSA

Cell Culture Grade Recombinant Human Albumin / 66.5 KDa Recombinant HSA
Cell Culture Grade Recombinant Human Albumin / 66.5 KDa Recombinant HSA

Large Image :  Cell Culture Grade Recombinant Human Albumin / 66.5 KDa Recombinant HSA

Product Details:
Place of Origin: Wuhan, China (Mainland)
Brand Name: Oryzogen
Certification: ISO9001:2015 certificate
Model Number: HYC002M01
Payment & Shipping Terms:
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: 1g, 10g, 50g and 100g
Delivery Time: 3~5 days
Payment Terms: T/T
Supply Ability: 1000kg
Detailed Product Description
Other Names: Recombinant HSA, RHSA, OsrHSA Source: Rice Grain (Oryza Sativa)
Physical Appearance: Off-white To Light Beige Lyophilized Powder Formulation: No Stabilizer Or Surface Active Agent
Amino Acid Sequence: Same As The HSA From Plasma Product Type: Recombinant Protein
High Light:

Recombinant Human Albumin 66.5 kDa

,

Cell culture Recombinant Human Albumin

,

66.5 kDa recombinant HSA

 

Cell culture grade recombinant human albumin powder

 

Human serum albumin (HSA) is the major protein component of human plasma with content of 42±3.5 g/L. It consists of three domains composed of 585 amino acids forming a heart-shaped molecule with molecular weight of 66.5 kDa. HSA is synthelized in the liver and is mainly responsible for maintaining normal osmolarity in the blood circulation system, a carrier for numerous small molecules. HSA is widely used clinically to treat serious burn injuries, hemorrhagic shock and ascites caused by cirrhosis, and as an excipient for vaccines or therapeutic protein drugs, and as a cell culture medium supplement in the production of vaccines and pharmaceuticals.

 

Currently, commercial production of HSA is primarily based on collected human plasma, which is limited in supply but of high biopharmaceutical demand. To eliminate the potential risk of plasma derived contamination, regulatory agencies have encouraged pharmaceutical companies to use non-animal-derived sources for pharmaceutical production. Here Healthgen Biotech used rice seeds as a bioreactor for large-scale production of recombinant human albumin (OsrHSA). OsrHSA can be highly and stably expressed in rice seeds and can be processed cost-effectively. OsrHSA is determined to be equivalent to pHSA in terms of biochemical properties, physical structure, functions, biologic safety and immunogenicity.

 

In cell culture, the OsrHSA has such advantages:

  1. Avoid the serum quality changes from different batches, improve the repeatability of cell culture and experiment results.
  2. Avoid the toxic effects and serum-derived contamination from serum to cells.
  3. Avoid the impact of serum components in the experimental study.
  4. Benefit to the differentiation of cultured cells in vitro.
  5. Improvde the target proteins expression level and make the cell products easily purified. OsrHSA can be used as the nutrition and protein carrier. In addition, OsrHSA can enhance the viscosity of the medium and protect the cells from mechanical damage.

 

Cell Culture Grade Recombinant Human Albumin / 66.5 KDa Recombinant HSA 0

In the Mesenchymal Stem Cells (MSCs) culture, the adhesion and proliferation of MSCs in OsrHSA are similar as serum culture.

 

Contact Details
Wuhan Healthgen Biotechnology Corp.

Contact Person: cjing

Tel: +8615071115810

Send your inquiry directly to us (0 / 3000)